TELO שווי כולל של נכסי החברה Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals (TELO) operates as a life-extension startup, fully outsourcing substance synthesis and preclinical trials to external contractors. This chart illustrates a market valuation of total assets at 27.41. Such a model minimizes capital expenditures during the initial stage. Meanwhile, Telomir Pharmaceuticals (TELO) is implementing algorithmization to combat cellular aging, although the final testing stage and medical supervision remain under human control.

This indicator reflects the dynamic market value of all Telomir Pharmaceuticals (TELO) resources, calculated inversely via ROA to assess the current capital volume accounting for technological revaluation. An analysis of total asset value confirms that in longevity biotechnologies, asset value depends on scientific breakthroughs rather than macroeconomic cycles, determining the fundamental stability of investment capital.